Editorial Open Access
Like 2
Preview this article:

There is no abstract available.


Article metrics loading...

Loading full text...

Full text loading...



  1. Elston JW, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014-15 Ebola outbreak. Public Health. 2017;143:60-70.  https://doi.org/10.1016/j.puhe.2016.10.020  PMID: 28159028 
  2. Health and Safety Executive (HSE). The Approved List of biological agents. London: HSE; 2013. Available from: http://www.hse.gov.uk/pubns/misc208.pdf
  3. Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). Luxembourg: Publications Office of the European Union; 17 Oct 2000. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32000L0054
  4. European Centre for Disease Prevention and Control (ECDC). Rapid Risk Assessment. Crimean-Congo haemorrhagic fever in Spain. Stockholm: ECDC; 8 Sep 2016. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/crimean-congo-haemorrhagic-fever-spain-risk-assessment.pdf
  5. Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus infection. BMJ. 1977;2(6086):541-4.  https://doi.org/10.1136/bmj.2.6086.541  PMID: 890413 
  6. World Health Organization (WHO). Ebola virus disease – Spain. Geneva: WHO; 9 Oct 2014. Available from: http://www.who.int/csr/don/09-october-2014-ebola/en/
  7. Negredo A, de la Calle-Prieto F, Palencia-Herrejón E, Mora-Rillo M, Astray-Mochales J, Sánchez-Seco MP, et al. Autochthonous Crimean-Congo Hemorrhagic Fever in Spain. N Engl J Med. 2017;377(2):154-61.  https://doi.org/10.1056/NEJMoa1615162  PMID: 28700843 
  8. Grahn A, Bråve A, Lagging M, Dotevall L, Ekqvist D, Hammarström H, et al. Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing Deficit. Open Forum Infect Dis. 2016;3(4):ofw198.  https://doi.org/10.1093/ofid/ofw198  PMID: 27975074 
  9. Kitching A, Addiman S, Cathcart S, Bischop L, Krahé D, Nicholas M, et al. A fatal case of Lassa fever in London, January 2009. Euro Surveill. 2009;14(6).
  10. Atkin S, Anaraki S, Gothard P, Walsh A, Brown D, Gopal R, et al. The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveill. 2009;14(10):19145. PMID: 19317988 
  11. Conger NG, Paolino KM, Osborn EC, Rusnak JM, Günther S, Pool J, et al. Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerg Infect Dis. 2015;21(1):23-31.  https://doi.org/10.3201/eid2101.141413  PMID: 25529825 
  12. Barr DA, Aitken C, Bell DJ, Brown CS, Cropley I, Dawood N, et al. First confirmed case of Crimean-Congo haemorrhagic fever in the UK. Lancet. 2013;382(9902):1458.  https://doi.org/10.1016/S0140-6736(13)61718-3  PMID: 24243135 
  13. Lumley S, Atkinson B, Dowall S, Pitman J, Staplehurst S, Busuttil J, et al. Non-fatal case of Crimean-Congo haemorrhagic fever imported into the United Kingdom (ex Bulgaria), June 2014. Euro Surveill. 2014;19(30):20864.  https://doi.org/10.2807/1560-7917.ES2014.19.30.20864  PMID: 25108534 
  14. Leligdowicz A, Fischer WA 2nd, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, et al. Ebola virus disease and critical illness. Crit Care. 2016;20(1):217.  https://doi.org/10.1186/s13054-016-1325-2  PMID: 27468829 
  15. Lehmann C, Kochanek M, Abdulla D, Becker S, Böll B, Bunte A, et al. Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Euro Surveill. 2017;22(39).  https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00088 
  16. Ehlkes L, George M, Samosny G, Burckhardt F, Vogt M, Bent S, et al. Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. Euro Surveill. 2017;22(39).  https://doi.org/10.2807/1560-7917.ES.2017.22.39.16-00728 
  17. Beeching NJ, Fletcher TE, Hill DR, Thomson GL. Travellers and viral haemorrhagic fevers: what are the risks? Int J Antimicrob Agents. 2010;36(Suppl 1):S26-35.  https://doi.org/10.1016/j.ijantimicag.2010.06.017  PMID: 20705436 
  18. Crowcroft NS. Management of Lassa fever in European countries. Euro Surveill. 2002;7(3):50-2. PMID: 12631947 
  19. Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, Albariño CG, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008;4(4):e1000047.  https://doi.org/10.1371/journal.ppat.1000047  PMID: 18421377 
  20. de Manzione N, Salas RA, Paredes H, Godoy O, Rojas L, Araoz F, et al. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin Infect Dis. 1998;26(2):308-13.  https://doi.org/10.1086/516299  PMID: 9502447 
  21. Maiztegui JI. Clinical and epidemiological patterns of Argentine haemorrhagic fever. Bull World Health Organ. 1975;52(4-6):567-75. PMID: 1085212 
  22. Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West African sub-region: an overview. J Vector Borne Dis. 2007;44(1):1-11. PMID: 17378212 
  23. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, Palacios G, et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 2009;5(5):e1000455.  https://doi.org/10.1371/journal.ppat.1000455  PMID: 19478873 
  24. Patterson M, Grant A, Paessler S. Epidemiology and pathogenesis of Bolivian hemorrhagic fever. Curr Opin Virol. 2014;5:82-90.  https://doi.org/10.1016/j.coviro.2014.02.007  PMID: 24636947 
  25. Ellwanger JH, Chies JA. Keeping track of hidden dangers - The short history of the Sabiá virus. Rev Soc Bras Med Trop. 2017;50(1):3-8.  https://doi.org/10.1590/0037-8682-0330-2016  PMID: 28327796 
  26. Chan M. Yellow fever: the resurgence of a forgotten disease. Lancet. 2016;387(10034):2165-6.  https://doi.org/10.1016/S0140-6736(16)30620-1  PMID: 27229187 
  27. Rougeron V, Feldmann H, Grard G, Becker S, Leroy EM. Ebola and Marburg haemorrhagic fever. J Clin Virol. 2015;64:111-9.  https://doi.org/10.1016/j.jcv.2015.01.014  PMID: 25660265 
  28. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100(1):159-89.  https://doi.org/10.1016/j.antiviral.2013.07.006  PMID: 23906741 
  29. Linthicum KJ, Britch SC, Anyamba A. Rift Valley Fever: An Emerging Mosquito-Borne Disease. Annu Rev Entomol. 2016;61:395-415.
  30. Yoshikawa T, Shimojima M, Fukushi S, Tani H, Fukuma A, Taniguchi S, et al. Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan. J Infect Dis. 2015;212(6):889-98.  https://doi.org/10.1093/infdis/jiv144  PMID: 25762790 
  31. World Health Organization (WHO). List of Blueprint priority diseases. Geneva: WHO; [Accessed Sep 2017]. Available from: http://www.who.int/blueprint/priority-diseases/en/

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error